Apollo Micro Systems Shares Rally 4% on Securing Manufacturing License
Shares of Apollo Micro Systems Ltd rallied 4% on 2 December after the company announced that it had secured a 15-year manufacturing licence from the
Home
Page 109
Syrma SGS Drops 2.25% as Work Begins on New Andhra PCB Plant
Shares of Syrma SGS Technology Ltd dropped 2.25% after touching a day’s high of Rs 821.95 on 2nd December, despite the company saying on Monday
Bharat Dynamics Shares Gain 1% on Securing Orders from the Indian Army
Shares of Bharat Dynamics Ltd were trading 1.5% higher on 2 December after the company received further orders worth Rs 2461.62 crore from the Indian
Tata Communications Flat as Unit Buys 51% Stake in US AI Firm for Rs 227 Crore
Shares of Tata Communications Ltd are trading flat after touching a day’s high of Rs 1,854.30 on 2nd December. This occurred even as the company
Stocks in Focus: Bharat Dynamics, Amber Enterprises, and Others
The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading lower by 2 points at 26,332, indicating that the
Overnight Stock Market Movements: Key Developments
The Indian stock market’s key indices, Sensex and Nifty 50, are likely to open flat on Tuesday as global markets offer mixed overnight signals. Most
Stocks Under F&O Ban: Sammaan Capital
Under the futures and options (F&O) segment, no stocks were banned from trade on Tuesday, 2 December, by the National Stock Exchange (NSE). The securities
India Directs Smartphone Makers to Preload Govt Cyber Safety App
India is taking a tougher stance on mobile security. It is quietly directing smartphone makers to include its state-owned cybersecurity app, Sanchar Saathi, on every
Fadnavis Govt Turns 1: Infra, Investments, Alliance Focus
As the Fadnavis-led Mahayuti government approaches its first anniversary on 5th December, the year has been defined by an aggressive infrastructure push. Efforts to reassure
Sun Pharma Rolls Out Ilumya in India; Stock Ends 1.25% Lower
Shares of Sun Pharma Industries Ltd ended 1.25% lower on 1st December, even as the firm announced the launch of its global innovative drug, Ilumya